Liver transplantation and inflammatory bowel disease. (Q54334561)

27 May 2018

review article

1 reference

title

Liver transplantation and inflammatory bowel disease. (English)

1 reference

27 May 2018

inflammatory bowel diseases

main subject

0 references

liver transplantation

1 reference

inferred from title

author

George Papatheodoridis

1

1 reference

27 May 2018

author name string

Hamilton M

2

1 reference

27 May 2018

Rolles K

3

1 reference

27 May 2018

Burroughs AK

4

1 reference

27 May 2018

publication date

1 June 1998

1 reference

27 May 2018

published in

Journal of Hepatology

1 reference

27 May 2018

volume

28

1 reference

27 May 2018

issue

6

1 reference

27 May 2018

page(s)

1070-1076

1 reference

27 May 2018

Hepatobiliary manifestations of inflammatory bowel disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Sclerosing cholangitis in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Orthotopic liver transplantation for primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

The role of orthotopic liver transplantation in the management of sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Ulcerative colitis disease activity as subjectively assessed by patient-completed questionnaires following orthotopic liver transplantation for sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

The Interrelation Between Sclerosing Cholangitis and Ulcerative Colitis in Patients Undergoing Liver Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Inflammatory bowel disease in primary sclerosing cholangitis: An analysis of patients undergoing liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Low-Dose Cyclosporine for the Treatment of Crohn's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

European trial of cyclosporine in chronic active Crohn's disease: a 12-month study. The European Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Peripheral blood CD3 and CD4 T-lymphocyte reduction correlates with severity of liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn's disease and ulcerative colitis): a review

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

The Effects of Azathioprine and 6 mp on Immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Immunosuppressant therapy of inflammatory bowel disease. Pharmacologic and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

FK 506 for liver, kidney, and pancreas transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Autoimmunity and ulcerative colitis: can two enigmas make sense together?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Ulcerative colitis and colorectal cancer. A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Risk of colorectal neoplasia in patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Cancers following cyclosporine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980359-0

7 January 2021

10.1016/S0168-8278(98)80359-0

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018